Skip to main content
SpringerLink
Log in

High mean platelet volume, low-grade systemic coagulation and fibrinolytic activation are associated with androgen and insulin levels in polycystic ovary syndrome

  • Original Article
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Objectives

The present study was designed to determine (a) the coagulation parameters, WBC and MPV levels; (b) whether there was any association between androgen and mean platelet volume and low-grade systemic coagulation in PCOS patients.

Methods

A total of 48 patients with non-diabetic PCOS were studied in order to evaluate and compare with a non-PCOS group of 30 subjects.

Results

D-dimer, homeostatic model assessment (HOMA-IR), insulin, androgens, glucose, WBC and MPV concentrations were higher in women with PCOS. No difference was observed in fibrinogen, activated partial thromboplastin time and prothrombin time values between the two groups. Free testosterone was positively correlated with D-dimer, insulin, DHEAS, and MPV levels. In multiple stepwise regression analyses, free testosterone positively associated with D-dimer and DHEAS. MPV was positively correlated with insulin levels, HOMA-IR values, DHEAS and free testosterone levels in PCOS patients. In multiple stepwise regression analyses, MPV positively associated with insulin and DHEAS.

Conclusion

PCOS patients had low-grade systemic coagulation and fibrinolytic activation as evidenced by elevated D-dimer, and increased WBC and MPV levels suggesting that hematological parameters could potentially be used as indicators of risk factor for atherosclerosis in PCOS women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Franks S (1995) Polycystic ovary syndrome. N Engl J Med 333:853–861

    Article  PubMed  CAS  Google Scholar 

  2. Atiomo WU, Bates SA, Condon JE, Shaw S, West JH, Prentice AG (1998) The plasminogen activator system in women with polycystic ovary syndrome. Fertil Steril 69(2):236–241

    Article  PubMed  CAS  Google Scholar 

  3. Tarkun I, Canturk Z, Arslan BC, Turemen E, Tarkun P (2004) The plasminogen activator system in young and lean women with polycystic ovary syndrome. Endocr J 51:467–472

    Article  PubMed  CAS  Google Scholar 

  4. Yildiz BO, Haznedaroğlu IC, Kirazli S, Bayraktar M (2002) Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state. J Clin Endocrinol Metab 87(8):3871–3875

    Article  PubMed  CAS  Google Scholar 

  5. Słopień R, Lewandowski K, Kolacz E, Zawilska K, Warenik-Szymankiewicz A (2006) Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity. Gynecol Endocrinol 22(11):651–654

    Article  PubMed  Google Scholar 

  6. Kelly CJ, Lyall H, Petrie JR, Gould GW, Connell JM, Rumley A, Lowe GD, Sattar N (2002) A specific elevation in tissue plasminogen activator antigen in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 87(7):3287–3290

    Article  PubMed  CAS  Google Scholar 

  7. Danesh J, Collins R, Appleby P et al (1998) Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279:1477–1482

    Article  PubMed  CAS  Google Scholar 

  8. Horne BD, Anderson JL, John JM, Intermountain Heart Collabarative Study Group et al (2005) Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 45:1638–1643

    Article  PubMed  Google Scholar 

  9. Orio F Jr, Palomba S, Cascella T, Di Biase S, Manguso F, Tauchmanova L, Nardo LG, Labella D, Savastano S, Russo T, Zullo F, Colao A, Lombardi G (2005) The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. J Clin Endocrinol Metab 90:2–5

    Article  PubMed  CAS  Google Scholar 

  10. Hekimsoy Z, Payzin B, Ornek T, Kandoğan G (2004) Mean platelet volume in type 2 diabetic patients. J Diabetes Complicat 18(3):173–176

    Article  PubMed  Google Scholar 

  11. Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY (2004) Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol 44(2):415–422

    Article  PubMed  Google Scholar 

  12. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria, long-term health risks related to polycystic ovary syndrome PCOS. Hum Reprod 19:41–47

    Article  Google Scholar 

  13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419

    Article  PubMed  CAS  Google Scholar 

  14. Koenig W (1998) Haemostatic risk factors for cardiovascular diseases. Eur Heart J 19:C39–C43

    PubMed  Google Scholar 

  15. Yang A, Pizzulli L, Luderitz B (2006) Mean platelet volume as a marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris. Thromb Res 117:371–377

    Article  PubMed  CAS  Google Scholar 

  16. Glud T, Schnidt EB, Kristensen SD et al (1986) Platelet number and volume during myocardial infarction in relation to infarct size. Acta Med Scand 220:401–405

    PubMed  CAS  Google Scholar 

  17. Ylmanaz MB, Akin Y, Biyikoglu SF et al (2004) Left ventricular thrombosis is associated with increased mean platelet volume in patients with dilated cardiomyopathy and sinus rhythm. Acta Cardiol 59:41–45

    Article  Google Scholar 

  18. Martin JF, Trowbridge EA, Salmon G, Plumb J (1983) The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 32(5):443–460

    Article  PubMed  CAS  Google Scholar 

  19. Jakubowski JA, Thompson CB, Vaillancourt R et al (1983) Arachidonic acid metabolism by platelets of differing size. Br J Haematol 53:503–511

    Article  PubMed  CAS  Google Scholar 

  20. Gillum RF, Mussolino ME, Madans JH (2005) Counts of neutrophils, lymphocytes, and monocytes cause specific mortality and coronary heart disease: the NHANES-I epidemiologic follow-up study. Ann Epidemiol 15(4):266–271

    Article  PubMed  CAS  Google Scholar 

  21. Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Safford M, Grimm RH Jr, Howard BV, Assaf AR, Prentice R, Women’s Health Initiative Research Group (2005) Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women’s Health Initiative Observational Study. Arch Intern Med 165(5):500–508

    Article  PubMed  Google Scholar 

  22. Ross R (1999) Atherosclerosis: an inflammatory diesase. N Engl J Med 340:115–126

    Article  PubMed  CAS  Google Scholar 

  23. Galvani M, Ferrini D, Ghezzi F, Ottani F (2001) Cardiac markers and risk stratification: an integrated approach. Clin Chim Acta 311(1):9–17

    Article  PubMed  CAS  Google Scholar 

  24. Hsieh CH, Pei D, Kuo SW, Chen CY, Tsai SL, Lai CL, Lee CH, Wu CZ, Hung YJ, Hsieh MC (2007) Correlation between white blood cell count and metabolic syndrome in adolescence. Pediatr Int 49(6):827–832

    Article  PubMed  CAS  Google Scholar 

  25. Wang YY, Lin SY, Liu PH, Cheung BM, Lai WA (2004) Association between hematological parameters and metabolic syndrome components in a Chinese population. J Diabetes Complicat 18(6):322–327

    Article  PubMed  Google Scholar 

  26. Chuo SK, Li JC, Tsai WC, Wu DA, Kuo SW, Pei D, Chen SP, Shen DC (2005) Correlations between white blood cell count and metabolic syndrome in middle-age Taiwanese. Endocr Res 31(1):39–50

    Article  PubMed  Google Scholar 

  27. Park SH, Kang JM, Kim BS, Kim BJ, Sung KC, Kang JH, Lee MH, Park JR (2004) Relationship between peripheral leukocyte count and the severity of stable angina determined by coronary angiography. Korean J Intern Med 19(2):99–103

    PubMed  Google Scholar 

  28. Hasegawa T, Watase H (2003) Association of heart rate with coronary risk factors and increased white blood cell counts in healthy Japanese people. J Atheroscler Thromb 10(4):259–263

    PubMed  Google Scholar 

  29. Papanas N, Symeonidis G, Maltezos E et al (2004) Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 15:475–478

    Article  PubMed  CAS  Google Scholar 

  30. Oh JY, Barrett-Connor E, Wedick NM, Wingard DL (2002) Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo Study. Diabetes Care 25:55–60

    Article  PubMed  CAS  Google Scholar 

  31. Goodman-Gruen D, Barrett-Connor E (2000) Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care 23:912–918

    Article  PubMed  CAS  Google Scholar 

  32. Khaw KT, Barrett-Connor E (1991) Fasting plasma glucose levels and endogenous androgens in non-diabetic postmenopausal women. Clin Sci 80:199–203

    PubMed  CAS  Google Scholar 

Download references

Conflict of interest statement

None.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Bozyaka Training and Research Hospital, 123/4 Street, No. 10A, Flat 4, Izmir, Turkey

    Levent Kebapcilar

  2. Department of Obstetrics and Gynecology, Aegean Obstetrics and Gynecology Teaching Hospital, Izmir, Turkey

    Cuneyt Eftal Taner & Ayse Gul Kebapcilar

  3. Department of Internal Medicine, Bozyaka Training and Research Hospital, Izmir, Turkey

    Ismail Sari

Authors
  1. Levent Kebapcilar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cuneyt Eftal Taner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ayse Gul Kebapcilar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ismail Sari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Levent Kebapcilar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kebapcilar, L., Taner, C.E., Kebapcilar, A.G. et al. High mean platelet volume, low-grade systemic coagulation and fibrinolytic activation are associated with androgen and insulin levels in polycystic ovary syndrome. Arch Gynecol Obstet 280, 187–193 (2009). https://doi.org/10.1007/s00404-008-0884-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-008-0884-0

Keywords

Search

Navigation